--- title: "Pembina Pipeline Corp. Stock 12‑Month Price Target Raised to $47.29, Implies 3% Downside" type: "News" locale: "en" url: "https://longbridge.com/en/news/286754353.md" description: "Pembina Pipeline Corp.'s 12-month stock price target has been raised to $47.29, indicating a potential downside of 3% from the May 15 closing price. The average target, based on 17 analysts, ranges from $39.98 to $51.61. The consensus rating remains 'Buy' with 11 Buys, 7 Holds, and 2 Sells among 20 analysts." datetime: "2026-05-18T10:20:08.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286754353.md) - [en](https://longbridge.com/en/news/286754353.md) - [zh-HK](https://longbridge.com/zh-HK/news/286754353.md) --- # Pembina Pipeline Corp. Stock 12‑Month Price Target Raised to $47.29, Implies 3% Downside - According to estimates from 17 analysts, Pembina Pipeline Corp. stock's average price target has risen from $46.99 to $47.29, with forecasts ranging from $39.98 to $51.61 per share - Based on the May 15 closing price, the updated target implies approximately 3% potential downside - Consensus rating remains at “Buy” across 20 covering analysts, with 11 Buys, 7 Holds and 2 Sells Explore more price target data and ratings for Pembina Pipeline Corp. on the , and track all previous and future analyst recommendations for Pembina Pipeline Corp. in the dedicated News Flow. **Disclaimer** Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice. ### Related Stocks - [PBA.US](https://longbridge.com/en/quote/PBA.US.md) - [FDS.US](https://longbridge.com/en/quote/FDS.US.md) ## Related News & Research - [CANADA RESEARCH ROUNDUP-Keyera, Pembina Pipeline, Stantec](https://longbridge.com/en/news/286872560.md) - [Pembina Pipeline (PBA) Projected to Post Quarterly Earnings on Thursday](https://longbridge.com/en/news/284722648.md) - [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md) - [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md) - [Earnings Beat: Deepak Nitrite Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286980047.md)